EA200601030A1 - 7α,17α-ЗАМЕЩЁННЫЕ 11β-ГАЛОГЕНОСТЕРОИДЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ НА ИХ ОСНОВЕ - Google Patents
7α,17α-ЗАМЕЩЁННЫЕ 11β-ГАЛОГЕНОСТЕРОИДЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ НА ИХ ОСНОВЕInfo
- Publication number
- EA200601030A1 EA200601030A1 EA200601030A EA200601030A EA200601030A1 EA 200601030 A1 EA200601030 A1 EA 200601030A1 EA 200601030 A EA200601030 A EA 200601030A EA 200601030 A EA200601030 A EA 200601030A EA 200601030 A1 EA200601030 A1 EA 200601030A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- substituted
- methods
- pharmaceutical preparation
- halogenosteroids
- reception
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J11/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/06—Hydroxylating
- C12P33/08—Hydroxylating at 11 position
- C12P33/10—Hydroxylating at 11 position at 11 alpha-position
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P33/00—Preparation of steroids
- C12P33/12—Acting on D ring
- C12P33/16—Acting at 17 position
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Reproductive Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
В заявке описываются новые соединения, представляющие собой 7α,17α-замещенные 11β-галогенстероиды общей формулы (8,10,12)способы их получения, применение и фармацевтический препарат на их основе.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10233723A DE10233723A1 (de) | 2002-07-24 | 2002-07-24 | Mikrobiologische Verfahren zur Herstellung von 7α-substituierten 11α-Hydroxysteroiden, daraus herstellbare 7α,17α-substituierte 11β-Halogensteroide, deren Herstellungsverfahren und Verwendung sowie pharmazeutische Präparate, die diese Verbindungen enthalten, sowie daraus herstellbare 7α-substituierte Estra-1,3,5(10)-triene |
US40295302P | 2002-08-14 | 2002-08-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200601030A1 true EA200601030A1 (ru) | 2006-10-27 |
EA010572B1 EA010572B1 (ru) | 2008-10-30 |
Family
ID=31189296
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200500224A EA008147B1 (ru) | 2002-07-24 | 2003-07-24 | МИКРОБИОЛОГИЧЕСКИЕ СПОСОБЫ ПОЛУЧЕНИЯ 7α-ЗАМЕЩЁННЫХ 11α-ГИДРОКСИСТЕРОИДОВ |
EA200601030A EA010572B1 (ru) | 2002-07-24 | 2003-07-24 | 7α,17α-ЗАМЕЩЕННЫЕ 11β-ГАЛОГЕНОСТЕРОИДЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ НА ИХ ОСНОВЕ |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200500224A EA008147B1 (ru) | 2002-07-24 | 2003-07-24 | МИКРОБИОЛОГИЧЕСКИЕ СПОСОБЫ ПОЛУЧЕНИЯ 7α-ЗАМЕЩЁННЫХ 11α-ГИДРОКСИСТЕРОИДОВ |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1523568A2 (ru) |
JP (1) | JP4417838B2 (ru) |
KR (1) | KR101041328B1 (ru) |
CN (1) | CN100339486C (ru) |
BR (1) | BR0313210A (ru) |
CA (1) | CA2492079C (ru) |
CO (1) | CO5690563A2 (ru) |
CR (1) | CR7672A (ru) |
EA (2) | EA008147B1 (ru) |
EC (1) | ECSP055630A (ru) |
HK (1) | HK1081999A1 (ru) |
HR (1) | HRP20050172A2 (ru) |
IL (1) | IL166358A0 (ru) |
MX (1) | MXPA05001024A (ru) |
NO (1) | NO20050980L (ru) |
NZ (2) | NZ549529A (ru) |
PH (1) | PH12005500143B1 (ru) |
PL (1) | PL373808A1 (ru) |
RS (1) | RS51855B (ru) |
WO (1) | WO2004011663A2 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7935838B2 (en) * | 2005-10-27 | 2011-05-03 | Sri International | Process for production of steroid compound |
CN103834712B (zh) * | 2012-11-26 | 2016-03-30 | 复旦大学 | 去氧孕烯中间体纳米脂质体生物转化的优化方法 |
CN103214543B (zh) * | 2012-12-25 | 2015-09-02 | 中国人民解放军海军医学研究所 | 新山楂酸衍生物、其制备方法及其在抗肿瘤药物中的应用 |
CN104862323B (zh) * | 2015-06-02 | 2018-01-16 | 中国农业科学院生物技术研究所 | 修饰苯二酚类化合物的羟化酶基因 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL75841C (ru) | 1949-06-11 | |||
US2658023A (en) * | 1953-04-21 | 1953-11-03 | Pfizer & Co C | Oxygenation of steroids |
US2985563A (en) * | 1958-11-13 | 1961-05-23 | Schering Corp | 11alpha-hydroxylation of steroids by glomerella |
US3004047A (en) * | 1959-03-13 | 1961-10-10 | Olin Mathieson | 6alpha-halo-11alpha-hydroxy steroids of the pregnane series and esters thereof |
US3341557A (en) * | 1961-06-05 | 1967-09-12 | Upjohn Co | 7-methyltestosterones |
US3203869A (en) * | 1962-10-11 | 1965-08-31 | Syntex Corp | 11alpha-hydroxylation of 6-substituted-11-desoxy steroids with microorganisms of thegenus fusarium, liseola section |
US5342834A (en) | 1989-04-07 | 1994-08-30 | The Population Council, Inc. | Method for androgen supplementation |
EP1170299A3 (en) * | 1995-12-11 | 2004-11-10 | G.D. Searle & Co. | Intermediates useful in the preparation of 9,11-epoxy steroids and methods for their production |
GB9525194D0 (en) | 1995-12-12 | 1996-02-07 | Zeneca Ltd | Pharmaceutical composition |
WO1997021830A1 (en) | 1995-12-12 | 1997-06-19 | Akzo Nobel N.V. | MICROBIAL 11α-HYDROXYLATION OF STEROIDS |
US20020012694A1 (en) * | 1997-09-17 | 2002-01-31 | Alfred J. Moo-Young | Transdermal administration of ment |
US6767902B2 (en) | 1997-09-17 | 2004-07-27 | The Population Council, Inc. | Androgen as a male contraceptive and non-contraceptive androgen replacement |
US5952319A (en) | 1997-11-26 | 1999-09-14 | Research Triangle Institute | Androgenic steroid compounds and a method of making and using the same |
RU2002124602A (ru) | 2000-02-15 | 2004-03-10 | Шеринг Акциенгезелльшафт (De) | Композиция для мужской контрацепции, включающая норэтистерон |
DE10104327A1 (de) * | 2001-01-24 | 2002-07-25 | Schering Ag | 11beta-Halogensteroide, deren Herstellung und Verwendung zur Herstellung von Arzneimitteln sowie 11beta-Halogensteroide enthaltende pharmazeutische Präparate |
CN1671394A (zh) * | 2002-07-25 | 2005-09-21 | 舍林股份公司 | 包含雄激素性11β-卤素甾体和孕激素的组合物以及基于该组合物的雄性避孕药 |
-
2003
- 2003-07-24 WO PCT/EP2003/008111 patent/WO2004011663A2/de active Application Filing
- 2003-07-24 EP EP03740474A patent/EP1523568A2/de not_active Withdrawn
- 2003-07-24 KR KR1020057001140A patent/KR101041328B1/ko not_active IP Right Cessation
- 2003-07-24 CA CA2492079A patent/CA2492079C/en not_active Expired - Fee Related
- 2003-07-24 NZ NZ549529A patent/NZ549529A/en not_active IP Right Cessation
- 2003-07-24 PL PL03373808A patent/PL373808A1/xx not_active Application Discontinuation
- 2003-07-24 CN CNB038176963A patent/CN100339486C/zh not_active Expired - Fee Related
- 2003-07-24 EA EA200500224A patent/EA008147B1/ru not_active IP Right Cessation
- 2003-07-24 MX MXPA05001024A patent/MXPA05001024A/es active IP Right Grant
- 2003-07-24 JP JP2004523777A patent/JP4417838B2/ja not_active Expired - Fee Related
- 2003-07-24 RS YU20050045A patent/RS51855B/sr unknown
- 2003-07-24 BR BR0313210-2A patent/BR0313210A/pt not_active IP Right Cessation
- 2003-07-24 NZ NZ537871A patent/NZ537871A/en not_active IP Right Cessation
- 2003-07-24 EA EA200601030A patent/EA010572B1/ru not_active IP Right Cessation
-
2005
- 2005-01-18 IL IL16635805A patent/IL166358A0/xx not_active IP Right Cessation
- 2005-01-21 PH PH12005500143A patent/PH12005500143B1/en unknown
- 2005-02-03 CR CR7672A patent/CR7672A/es not_active Application Discontinuation
- 2005-02-21 CO CO05015699A patent/CO5690563A2/es not_active Application Discontinuation
- 2005-02-22 HR HR20050172A patent/HRP20050172A2/hr not_active Application Discontinuation
- 2005-02-23 NO NO20050980A patent/NO20050980L/no not_active Application Discontinuation
- 2005-02-24 EC EC2005005630A patent/ECSP055630A/es unknown
-
2006
- 2006-02-17 HK HK06102071A patent/HK1081999A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2492079C (en) | 2012-01-10 |
MXPA05001024A (es) | 2005-05-16 |
EA010572B1 (ru) | 2008-10-30 |
CO5690563A2 (es) | 2006-10-31 |
WO2004011663A2 (de) | 2004-02-05 |
HK1081999A1 (en) | 2006-05-26 |
JP4417838B2 (ja) | 2010-02-17 |
PL373808A1 (en) | 2005-09-19 |
JP2006503813A (ja) | 2006-02-02 |
KR101041328B1 (ko) | 2011-06-14 |
WO2004011663A9 (de) | 2004-05-06 |
EA200500224A1 (ru) | 2005-08-25 |
ECSP055630A (es) | 2005-04-18 |
RS20050045A (en) | 2007-06-04 |
CN100339486C (zh) | 2007-09-26 |
CA2492079A1 (en) | 2004-02-05 |
PH12005500143B1 (en) | 2011-03-25 |
NZ549529A (en) | 2008-04-30 |
RS51855B (sr) | 2012-02-29 |
IL166358A0 (en) | 2006-01-16 |
NZ537871A (en) | 2006-10-27 |
HRP20050172A2 (en) | 2005-04-30 |
AU2003281677A1 (en) | 2004-02-16 |
BR0313210A (pt) | 2005-06-28 |
MX260952B (ru) | 2008-10-01 |
KR20050026507A (ko) | 2005-03-15 |
EP1523568A2 (de) | 2005-04-20 |
WO2004011663A3 (de) | 2004-07-15 |
CR7672A (es) | 2006-05-29 |
CN1671858A (zh) | 2005-09-21 |
NO20050980L (no) | 2005-02-23 |
EA008147B1 (ru) | 2007-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200700225A1 (ru) | Аналоги тетрапептида | |
SE0301700D0 (sv) | Novel compounds | |
WO2003095455A3 (en) | Substituted pyrazolopyrimidines | |
NO2014009I2 (no) | Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser | |
WO2005046603A3 (en) | Pyridine compounds | |
CY1109998T1 (el) | Ενδυναμωτες υποδοχεων γλουταμινικου | |
DK1656372T3 (da) | 2,4-pyrimidindiaminforbindelser til anvendelse til behandling eller forebyggelse af autoimmunsygdomme | |
EA200401169A1 (ru) | Аминометилзамещенные тетрациклиновые соединения | |
TW200510325A (en) | 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof | |
MX337423B (es) | Antagonistas anti-beta7 humanizados y usos para los mismos. | |
AU2002341920A1 (en) | Chemical compounds | |
BRPI0312649A2 (pt) | compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos. | |
SE0301653D0 (sv) | Novel compounds | |
NO20054535L (no) | Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme | |
SE0302139D0 (sv) | Novel compounds | |
NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
EA200700550A1 (ru) | Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств | |
AU2003290059A1 (en) | Use of cd137 antagonists for the treatment of tumors | |
WO2005054172A3 (en) | Jasmonate derivative compounds, pharmaceuticals compositions and methods of use thereof | |
MY138479A (en) | 7alpha-hydroxyacetyl and 7alpha-hydroperoxyacetyl-substituted steroid compounds | |
UA91988C2 (ru) | Фармацевтическая композиция на основе антагонистов nk2 для применения в педиатрии | |
EA200601030A1 (ru) | 7α,17α-ЗАМЕЩЁННЫЕ 11β-ГАЛОГЕНОСТЕРОИДЫ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ, ПРИМЕНЕНИЕ И ФАРМАЦЕВТИЧЕСКИЙ ПРЕПАРАТ НА ИХ ОСНОВЕ | |
WO2004050613A3 (en) | 2-substituted-3-propenamide derivatives and methods of using the same | |
ATE274515T1 (de) | Pyrazolopyridinderivate | |
BR0316544A (pt) | Compostos calcilìticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): BY RU |